In a 26-week henagliflozin trial, 90% of patients taking henagliflozin gained telomere length compared to 66% of patients receiving placebo
Agree
Disagree
Overview
Debates
Related claims
Topics
Activity
Debates
…
Claims
…
View all debates
Activity (0)
Join the conversation...
Loading comments...
Opening sign-in…